MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
NVO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

Novo-Nordisk A/S (NVO) Ownership - Who owns Novo-Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com

Details

Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
254.04B
P/E Ratio
14.43
Total Cash
N/A
Projected Growth
1.53
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
0.03
Total Cash/Share
N/A
Total Debt/Equity
2.39
Revenue/Share
10.97 USD as % of share price

Fundamentals

NVO
Capitalization
254B
P/E Ratio
14.43
Risk (Beta)
N/A
Dividend Yield
0.03
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
2.39
Projected Growth (PEG Ratio)
1.53
Revenue/Share (as % of the share price)
10.97%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
9.51
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
0.74
Current Revenue Per Employee
1008797.75
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
83.49
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
4.44B
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
-32.650
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Day Trader: Search for Dip TA&FA ($1500)Day Trader: Search for Dip TA&FA ($1500)
Annualized Return+10%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
NVO
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For NVO
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVO showed earnings on August 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com